News Overview | chemanager-online.com - Chemistry and Life Science

Dec. 12, 2019
News & OpinionsHeadlines
FTC Move Delays Bayer-Elanco Deal
Bayer’s planned sale of its animal health business to Eli Lilly’s veterinary spinoff Elanco in a $7.6 billion cash and stock deal, sealed in August this year, now faces a delay. ...
Dec. 11, 2019
News & OpinionsHeadlines
Archroma: Heike van de Kerkhof to Succeed Alexander Wessels as CEO
Heike van de Kerkhof has been appointed by Archroma’s board of directors to succeed current CEO Alexander Wessels effective Jan. 6, 2020. Wessels will be appointed as vice chairman of Archroma’s board of directors and will also ...
Dec. 11, 2019
News & OpinionsHeadlines
Huntsman Boosts PU Foam with Icynene-Lapolla
Huntsman has agreed to acquire Icynene-Lapolla, a distributor and manufacturer of spray polyurethane foam (SPF), from an affiliate of FFL Partners for $350 million cash. The transaction is expected to close in the first half of 2020.
Dec. 11, 2019
News & OpinionsHeadlines
Baltic Chemical Picks Univation PE Process
Additional details of the massive cracker complex being built by Russia’s Baltic Chemical, a wholly owned subsidiary of Russian gas group RusGasDobycha, at Ust-Luga near the Gulf of Finland have emerged.
Dec. 11, 2019
News & OpinionsHeadlines
ExxonMobil Prevails in New York Lawsuit
ExxonMobil has won a case brought against it by the US state of New York, which had charged that the energy group’s carbon accounting downplayed the financial risk of future climate regulations, thereby misleading investors. ...
Dec. 10, 2019
News & OpinionsHeadlines
BSEF Calls for Removal of EU Flame Retardant Ban
In a statement issued on the publication of the European Commission’s new Ecodesign requirements for electronic displays, the International Bromine Council (BSEF) called for the removal of the ban on halogenated flame retardants ...
Dec. 10, 2019
News & OpinionsHeadlines
IFF and Kerry in Slugfest over DuPont’s Nutrition Unit?
International Flavors & Fragrances (IFF) is reportedly battling it out with Ireland's Kerry Group to acquire DuPont’s nutrition unit planned to be spun off and sold, possibly in a Reverse Morris Trust, essentially a tax-free ...
Dec. 10, 2019
News & OpinionsHeadlines
Sanofi to Buy Synthorx for $2.5 Billion
French drugmaker Sanofi has signed a definitive agreement to buy Synthorx, a US clinical-stage US biotech focused on cancer and autoimmune disorders, for $68 per share. The cash offer is worth about $2.5 billion. ...

…5 6 789 10 11 12…

Register now!

The latest information directly via newsletter.

GIT Verlag